Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-076887

Options or other derivatives

  • Director acquired 660,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Allen Andrew R Director 2024-07-01 Grant or award · Option to purchase Ordinary Shares +660,000 660,000 D
Loading xslF345X05/tm2418639-1_4seq1.xml…